Sharps Technology, Inc. (NASDAQ:STSS) Short Interest Down 97.0% in October

Sharps Technology, Inc. (NASDAQ:STSS) saw a large decrease in short interest during the month of October. As of October 15th, there was short interest totalling 43,600 shares, a decrease of 97.0% from the September 30th total of 1,460,000 shares. Currently, 3.5% of the company’s stock are short sold. Based on an average daily trading volume, of 122,400 shares, the short-interest ratio is currently 0.4 days.

Sharps Technology Price Performance

Shares of Sharps Technology stock traded down $0.03 during trading hours on Friday, hitting $2.73. 37,994 shares of the company’s stock traded hands, compared to its average volume of 201,860. Sharps Technology has a twelve month low of $2.34 and a twelve month high of $18.15. The company has a market capitalization of $3.54 million, a PE ratio of -0.26 and a beta of 1.17.

Sharps Technology (NASDAQ:STSS) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($2.20) earnings per share for the quarter.

Sharps Technology Company Profile

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.